ES2175020T3 - Formulacion oftalmica para el uso en la cirugia ocular. - Google Patents

Formulacion oftalmica para el uso en la cirugia ocular.

Info

Publication number
ES2175020T3
ES2175020T3 ES96120457T ES96120457T ES2175020T3 ES 2175020 T3 ES2175020 T3 ES 2175020T3 ES 96120457 T ES96120457 T ES 96120457T ES 96120457 T ES96120457 T ES 96120457T ES 2175020 T3 ES2175020 T3 ES 2175020T3
Authority
ES
Spain
Prior art keywords
eye surgery
formulation
ophthalm
intraocular
damper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96120457T
Other languages
English (en)
Inventor
Rene-Pierre Bunter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trb Chemedica S A
Original Assignee
Trb Chemedica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trb Chemedica S A filed Critical Trb Chemedica S A
Application granted granted Critical
Publication of ES2175020T3 publication Critical patent/ES2175020T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION HACE REFERENCIA A UNA FORMULACION OFTALMICA, PARA UTILIZAR EN LA CIRUGIA DEL OJO, QUE INCLUYE HIALURONATO DE SODIO, CITRATO, AL MENOS UN ANTIOXIDANTE TOLERADO POR LOS TEJIDOS INTRAOCULARES Y UN AMORTIGUADOR DE FOSFATO.
ES96120457T 1995-12-22 1996-12-19 Formulacion oftalmica para el uso en la cirugia ocular. Expired - Lifetime ES2175020T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI002744A IT1277707B1 (it) 1995-12-22 1995-12-22 Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare

Publications (1)

Publication Number Publication Date
ES2175020T3 true ES2175020T3 (es) 2002-11-16

Family

ID=11372809

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96120457T Expired - Lifetime ES2175020T3 (es) 1995-12-22 1996-12-19 Formulacion oftalmica para el uso en la cirugia ocular.

Country Status (10)

Country Link
US (1) US5880107A (es)
EP (1) EP0781547B1 (es)
JP (1) JP4146910B2 (es)
AT (1) ATE216221T1 (es)
CA (1) CA2193543C (es)
DE (1) DE69620724T2 (es)
DK (1) DK0781547T3 (es)
ES (1) ES2175020T3 (es)
IT (1) IT1277707B1 (es)
PT (1) PT781547E (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541460B2 (en) 1996-08-07 2003-04-01 George D. Petito Method for use of hyaluronic acid in wound management
US6368585B1 (en) * 1997-03-25 2002-04-09 Pharmacia Ab Opthalmic compositions and methods
US20030138499A1 (en) * 1998-12-17 2003-07-24 Shah Mandar V. Stable surgical irrigating solutions
US6533769B2 (en) * 2001-05-03 2003-03-18 Holmen Joergen Method for use in cataract surgery
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
ITMI20020557A1 (it) * 2002-03-15 2003-09-15 Acraf Uso di un sale dell'acido l-ascorbico per preparare una composizione farmaceutica per uso topico oftalmico capace di migliorare il livello d
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20050215516A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo New free-radical scavenger containing viscoelastic composition, methods of use and package
US20060073184A1 (en) * 2004-09-29 2006-04-06 Bausch & Lomb Inc. Viscoelastic composition, methods of use and packaging device with anti-oxidant
WO2008042441A1 (en) * 2006-10-03 2008-04-10 Anthrogenesis Corporation Use of umbilical cord biomaterial for ocular surgery
WO2008147867A2 (en) * 2007-05-23 2008-12-04 Allergan, Inc. Cross-linked collagen and uses thereof
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) * 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
EP3498299A1 (en) 2007-11-16 2019-06-19 Aclaris Therapeutics, Inc. Compositions and methods for treating purpura
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
WO2009084044A1 (en) * 2007-12-27 2009-07-09 D.M.G. Italia Srl Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
EP2324064B1 (en) 2008-09-02 2017-11-08 Tautona Group LP Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US20100104654A1 (en) * 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
JP4885245B2 (ja) * 2009-01-15 2012-02-29 日本航空電子工業株式会社 Ｒｄコンバータ及び角度検出装置
WO2011075430A1 (en) * 2009-12-14 2011-06-23 University Of Massachusetts Methods of inhibiting cataracts and presbyopia
US20110171310A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US20110172180A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
AU2010348090B2 (en) 2010-03-12 2015-09-03 Allergan Industrie Sas A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition
EP4062950A1 (en) 2010-03-22 2022-09-28 Allergan, Inc. Syringe comprising dermal filler for soft tissue augmentation
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
JP6009550B2 (ja) 2011-06-03 2016-10-19 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 抗酸化物質を含む皮膚充填剤組成物
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US11058677B2 (en) * 2012-12-19 2021-07-13 Novartis Ag LFA-1 inhibitor formulations
AT514540A1 (de) * 2013-06-18 2015-01-15 Apomedica Pharmazeutische Produkte Gmbh Ophthalmische Zusammensetzung
US9492474B2 (en) 2013-07-10 2016-11-15 Matrix Biology Institute Compositions of hyaluronan with high elasticity and uses thereof
WO2015125921A1 (ja) * 2014-02-20 2015-08-27 わかもと製薬株式会社 保存効力を有する医薬用水性組成物
ES2761558T3 (es) 2014-09-30 2020-05-20 Allergan Ind Sas Composiciones de hidrogel estables que incluyen aditivos
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
KR20230058544A (ko) * 2015-08-18 2023-05-03 아스텔라스 인스티튜트 포 리제너러티브 메디슨 임상 제제
EP3842047B1 (en) 2015-09-24 2024-08-07 Matrix Biology Institute High elasticity hyaluronan compositions and methods of use thereof
JP2019532105A (ja) * 2016-10-14 2019-11-07 アイ．コム メディカル ゲーエムベーハー 角結膜のホメオスタシスを確立、回復及び維持するための方法
EP3713617A1 (en) * 2017-11-22 2020-09-30 Bausch & Lomb Incorporated Ophthalmic viscoelastic compositions
CN113354757B (zh) * 2021-06-26 2022-04-08 上海加新生物科技有限公司 一种小分子透明质酸钠的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US4886786A (en) * 1985-08-01 1989-12-12 Lindstrom Richard L Additive for irrigation solution or surgical solution
IL80298A (en) 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
US4920104A (en) * 1988-05-16 1990-04-24 Medchem Products, Inc. Sodium hyaluronate composition
JPH07116030B2 (ja) * 1990-06-29 1995-12-13 参天製薬株式会社 残留水晶体物質除去補助剤
WO1994007505A1 (en) * 1991-07-03 1994-04-14 Norpharmco Inc. Use of hyaluronic acid and forms to prevent arterial restenosis
JPH06107538A (ja) * 1992-03-31 1994-04-19 Shiseido Co Ltd 角膜移植用眼球保存液
JPH05310580A (ja) * 1992-04-30 1993-11-22 Shiseido Co Ltd 眼内灌流用液剤

Also Published As

Publication number Publication date
DE69620724D1 (de) 2002-05-23
CA2193543A1 (en) 1997-06-23
ITMI952744A0 (es) 1995-12-22
ATE216221T1 (de) 2002-05-15
US5880107A (en) 1999-03-09
IT1277707B1 (it) 1997-11-11
DE69620724T2 (de) 2002-11-21
CA2193543C (en) 2006-02-21
JPH09216826A (ja) 1997-08-19
EP0781547A1 (en) 1997-07-02
ITMI952744A1 (it) 1997-06-22
DK0781547T3 (da) 2002-08-12
JP4146910B2 (ja) 2008-09-10
EP0781547B1 (en) 2002-04-17
PT781547E (pt) 2002-09-30

Similar Documents

Publication Publication Date Title
ES2175020T3 (es) Formulacion oftalmica para el uso en la cirugia ocular.
BR9808282A (pt) Liberação controlada de produtos farmacêuticos na câmara anterior do olho
BRPI0411406A (pt) lente ocular tendo seletiva resposta espectral
ES2078325T3 (es) Aparato microquirurgico de laser libre de contacto.
BR9407330A (pt) Solução oftálmica baseada em diclofenaco e tobramicina e formulação oftálmica
ATE438117T1 (de) Binokulare linsensysteme
BR0302584A (pt) Combinação de brimonidina e timolol para uso oftálmico tópico
ATE213398T1 (de) Diffraktive/refraktive brillen- und intraokulare linsenkombination für altersbedingte makulardegenerierung
CY1106419T1 (el) Συστημα μετατροπης φακων για τηλεδιοπτρικες ή διαθλαστικες διαταξεις
ATE345096T1 (de) Mit einer translationszone ausgestattete intraokularlinse
EA199700286A1 (ru) Соединение для офтальмологической хирургии и способ ее осуществления
BR0108003A (pt) Lente intra-ocular de c mara anterior e métodos para reduzir a ovalização da pupila
WO2002019949A3 (en) Intraocular lens with a posterior lens portion
DE59802356D1 (de) Lagerstabile ophthalmische zusammensetzungen, umfassend diclofenac und ofloxacin
DK0868909T3 (da) Opthalmisk bæreropløsning
BR0107418A (pt) Lentes de contato que compreendem um corante laranja
AU5446299A (en) Medicinal compositions for treating eye diseases
ATE288241T1 (de) Farbige visko-elastische zusammensetzung
BR0210013A (pt) Gel oftálmico de pirenzepina
AR022099A1 (es) Una composicion oftalmica de liberacion sostenida y un metodo para terapia ocular
BR9107071A (pt) 2-decarboxil-2-aminoalquil-prostag landinas como hipotensivos oculares
BR112023024835A2 (pt) Lentes intraoculares com ópticas de mudança de formato e propriedades estabilizadoras
AR013273A1 (es) SISTEMA MATERIAL VISCOELÁSTICO GELIFICABLE FORMADO POR DOS PARTES CON POLíMEROS DE GALACTOMANANO Y BORATO.
BR9712308A (pt) Inibidor de catarata secundária
ES2078175B1 (es) Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 781547

Country of ref document: ES